Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced or Refractory Solid Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT03943004
What this trial is testing

Trial of DFP-14927 in Advanced Solid Tumors

Who this might be right for
Solid TumorCancer
Delta-Fly Pharma, Inc. 30
Early research (Phase 1)Temporarily pausedNCT00591682
What this trial is testing

MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumors
Metastatix, Inc. 27
Early research (Phase 1)Study completedNCT01495663
What this trial is testing

Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned

Who this might be right for
Cancer
Cellectar Biosciences, Inc. 12
Early research (Phase 1)Ended earlyNCT01227941
What this trial is testing

MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011)

Who this might be right for
Ovarian Cancer
Tesaro, Inc. 6
Early research (Phase 1)UnknownNCT00090727
What this trial is testing

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Solid MalignanciesNon-Hodgkin's Lymphoma
Novacea 45
Early research (Phase 1)Study completedNCT02214147
What this trial is testing

Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function

Who this might be right for
Advanced Solid TumorsRelapsed/Refractory Lymphoma
Millennium Pharmaceuticals, Inc. 36
Early research (Phase 1)Study completedNCT00611689
What this trial is testing

Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors

Who this might be right for
Refractory MalignancySolid Tumors
SCRI Development Innovations, LLC 45
Early research (Phase 1)Study completedNCT01288989
What this trial is testing

Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors

Who this might be right for
Neoplasms
Eli Lilly and Company 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06400160
What this trial is testing

Clinical Trial of TB511 in Advanced Solid Tumors

Who this might be right for
NSCLCProstate CancerColorectal Cancer+1 more
Twinpig Biolab, Inc. 12
Early research (Phase 1)Ended earlyNCT00359671
What this trial is testing

Treatment With MK6592 and an Anti-cancer Drug in Patients With Advanced Solid Tumors (6592-001)

Who this might be right for
Advanced Solid Tumors
Merck Sharp & Dohme LLC 38
Early research (Phase 1)Study completedNCT01764828
What this trial is testing

BAY86-9766 Plus Gemcitabine Phase I Study in Asian

Who this might be right for
Neoplasms
Bayer 23
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 884
Testing effectiveness (Phase 2)UnknownNCT01869166
What this trial is testing

Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR)

Who this might be right for
Advanced EGFR-positive Solid Tumors
Chinese PLA General Hospital 60
Early research (Phase 1)Study completedNCT02259010
What this trial is testing

Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma

Who this might be right for
Advanced Solid TumorsRelapsed/Refractory Lymphoma
Millennium Pharmaceuticals, Inc. 24
Early research (Phase 1)Study completedNCT01179295
What this trial is testing

Japanese BAY86-9766 Monotherapy Phase I Study

Who this might be right for
Neoplasms
Bayer 12
Early research (Phase 1)Active Not RecruitingNCT05104775
What this trial is testing

GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy

Who this might be right for
Hematologic Malignancies
Sichuan Baili Pharmaceutical Co., Ltd. 33
Early research (Phase 1)Study completedNCT01273168
What this trial is testing

Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

Who this might be right for
Hormone Receptor-Positive BreastGynecologicDesmoid+1 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT04902872
What this trial is testing

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
Solid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more
Cybrexa Therapeutics 69
Early research (Phase 1)Study completedNCT04659629
What this trial is testing

NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer

Who this might be right for
Solid TumorAdvanced Solid Tumor
Neurogene Inc. 59
Testing effectiveness (Phase 2)Study completedNCT01253837
What this trial is testing

L19TNFα in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsColorectal Cancer
Philogen S.p.A. 34
Next Page